Campbell & Co. Investment Adviser »

Trevi Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $890k 71k 12.52
2025-09-30 $228k 25k 9.15
2025-06-30 $75k 14k 5.47

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Vanguard Group
Vivo Capital
Marshall Wace
Alliancebernstein
Rubric Capital Management
FMR
MPM Oncology Impact Management
Wellington Management Company
Viking Global Investors
OrbiMed Advisors
Octagon Capital Advisors
Eventide Asset Management

View all funds holding Trevi Therapeutics